JPMorgan Chase & Co’s Fulcrum Therapeutics FULC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$180K Sell
26,162
-183,731
-88% -$1.26M ﹤0.01% 4511
2025
Q1
$604K Buy
209,893
+130,773
+165% +$377K ﹤0.01% 3912
2024
Q4
$372K Sell
79,120
-108,043
-58% -$508K ﹤0.01% 4276
2024
Q3
$668K Buy
187,163
+154,122
+466% +$550K ﹤0.01% 3864
2024
Q2
$205K Sell
33,041
-125,894
-79% -$781K ﹤0.01% 4268
2024
Q1
$1.5M Buy
158,935
+147,495
+1,289% +$1.39M ﹤0.01% 3332
2023
Q4
$77.2K Buy
11,440
+541
+5% +$3.65K ﹤0.01% 4871
2023
Q3
$48.4K Buy
10,899
+9,585
+729% +$42.6K ﹤0.01% 4920
2023
Q2
$4.34K Sell
1,314
-188,955
-99% -$624K ﹤0.01% 5301
2023
Q1
$543K Buy
190,269
+5,583
+3% +$15.9K ﹤0.01% 3779
2022
Q4
$1.35M Sell
184,686
-11,274
-6% -$82.1K ﹤0.01% 3208
2022
Q3
$1.59M Sell
195,960
-2,155
-1% -$17.4K ﹤0.01% 3071
2022
Q2
$971K Sell
198,115
-2,271
-1% -$11.1K ﹤0.01% 3497
2022
Q1
$4.74M Sell
200,386
-2,487
-1% -$58.8K ﹤0.01% 2603
2021
Q4
$3.59M Buy
202,873
+29,146
+17% +$516K ﹤0.01% 2800
2021
Q3
$4.9M Sell
173,727
-10,845
-6% -$306K ﹤0.01% 2590
2021
Q2
$1.93M Sell
184,572
-80,933
-30% -$848K ﹤0.01% 3242
2021
Q1
$3.13M Buy
265,505
+225,705
+567% +$2.66M ﹤0.01% 2961
2020
Q4
$466K Buy
39,800
+34,465
+646% +$404K ﹤0.01% 3787
2020
Q3
$41K Buy
5,335
+585
+12% +$4.5K ﹤0.01% 4341
2020
Q2
$87K Sell
4,750
-16,426
-78% -$301K ﹤0.01% 4011
2020
Q1
$253K Buy
21,176
+15,264
+258% +$182K ﹤0.01% 3609
2019
Q4
$99K Buy
5,912
+4,424
+297% +$74.1K ﹤0.01% 4026
2019
Q3
$10K Buy
+1,488
New +$10K ﹤0.01% 4566